Jove
Visualize
联系我们

相关概念视频

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion01:15

Blood Transfusion

457
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
457
Disorders of Hemostasis01:24

Disorders of Hemostasis

674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

937
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
937
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

446
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
446

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Blood loss due to diagnostic testing in extremely preterm infants in 22 European countries: a prospective observational study.

EClinicalMedicine·2026
Same author

The role of placental anastomoses in severe brain injury after fetal demise in monochorionic twins: a multicenter retrospective study.

American journal of obstetrics and gynecology·2026
Same author

Insights in fetal growth trajectories of spontaneous twin anemia polycythemia sequence twins.

Fetal diagnosis and therapy·2026
Same author

Early Prediction Model for Retinopathy of Prematurity Using Placental and Neonatal Risk Factors.

Investigative ophthalmology & visual science·2026
Same author

Peripheral blood cell counts of prematurely born, small for gestational age neonates.

Clinical and experimental pediatrics·2026
Same author

Alloimmunisation in pregnancy: current management and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: May 22, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

738

血小板输血和出血的风险

Valeria Cortesi1, Enrico Lopriore2, Susanna Fustolo-Gunnink3

  • 1Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands.

Seminars in fetal & neonatal medicine
|March 15, 2025
PubMed
概括

新生儿血小板输血可能会增加风险,挑战目前的指导方针. 新证据表明,专注于血小板计数以外的因素来评估新生儿出血风险.

更多相关视频

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

13.5K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

相关实验视频

Last Updated: May 22, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

738
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

13.5K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

科学领域:

  • 新生儿医学 新生儿医学
  • 血液学 血液学 血液学
  • 儿科重症监护 儿科重症监护

背景情况:

  • 新生儿出血是复杂的,血小板减少 (血小板数量低) 经常被错误地认为是主要原因.
  • 主要出血事件主要发生在非血小板缺血的新生儿中,这表明单独的血小板数量不足以预测出血风险.

研究的目的:

  • 重新评估血小板缺血在新生儿出血中的作用.
  • 质疑基于血小板计数门的血小板输血的历史实践.
  • 突出新出现的证据,将更高的输血门与新生儿的不良结果联系起来.

主要方法:

  • 对新生儿出血和血小板输血实践的现有文献的审查.
  • 对最近研究的分析,研究了血小板输血值与新生儿结局之间的关联.
  • 对血小板输血不良影响的拟议机制的探索.

主要成果:

  • 血小板缺血并不总是与新生儿严重出血有关.
  • 新生儿血小板输血值较高,与死亡,出血,支气管肺功能障碍和神经发育障碍的风险增加有关.
  • 这些不良影响的确切机制尚不清楚,假设包括输血血小板的非血静效应或血液动力学不稳定.

结论:

  • 目前关于新生儿血小板输血的指导方针需要修订,以纳入新的证据并采用更保守的门值.
  • 仅仅是血小板计数是评估新生儿出血风险的不足指标.
  • 未来的研究应该探索替代输血策略或更适合新生儿群体的产品.